Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2344-2352
Closed Access | Times Cited: 141

Showing 51-75 of 141 citing articles:

Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab versus placebo in resected stage III melanoma
Emanuel Buehrer, Nina Glassée, Michal Kiciński, et al.
EJC Skin Cancer (2025), pp. 100727-100727
Open Access
Gut microbiota and gastrointestinal tumors: insights from a bibliometric analysis
Chaofan Chen, Xiaolan Wang, Xu Han, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Gut microbiota affects PD-L1 therapy and its mechanism in melanoma
Shiqi Liu, Jiahui Liu, Yingwu Mei, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
The Gut Microbiome and Metastatic Renal Cell Carcinoma
Luís Meza, Matthew I. Feng, Kyle O. Lee, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1502-1502
Open Access | Times Cited: 11
Comparative Analysis of Fecal Microbiota in Vegetarians and Omnivores
Changbao Sun, Ang Li, Cong Xu, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2358-2358
Open Access | Times Cited: 11
Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors
Jinglong Huang, Caifeng Gong, Aiping Zhou
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 11
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile
Sean M. Anderson, Cynthia L. Sears
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_6, pp. S471-S478
Open Access | Times Cited: 11
Prognostic and predictive biomarkers in melanoma
Nigel Maher, Ismael A. Vergara, Georgina V. Long, et al.
Pathology (2023) Vol. 56, Iss. 2, pp. 259-273
Closed Access | Times Cited: 11
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
Eleftheria Chorti, Bernd Kowall, Jessica C. Hassel, et al.
European Journal of Cancer (2024) Vol. 200, pp. 113536-113536
Open Access | Times Cited: 4
Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies
Xuwen Lin, Mei Xie, Jie Yao, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 4
Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
Baike Liu, Zheran Liu, Tianxiang Jiang, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Eating away cancer: the potential of diet and the microbiome for shaping immunotherapy outcome
Ngoc-Trang Adrienne Nguyen, Yan Jiang, Jennifer L. McQuade
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen Chen, Peng Han, Yanping Qing
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103579-103579
Closed Access | Times Cited: 4
Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy
Ashutosh S. Yende, Dipali Sharma
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The Relationship Between the Modulation of Intestinal Microbiota and the Response to Immunotherapy in Patients with Cancer
Laura Radoš, Marin Golčić, Ivana Mikolašević
Biomedicines (2025) Vol. 13, Iss. 1, pp. 96-96
Open Access
Efficacy and safety of camrelizumab plus Lacticaseibacillus paracasei in the treatment of advanced esophageal squamous cell carcinoma: A single-arm, single-center, exploratory trial
Tengfei Zhang, Kang Cui, Xiaodan Liu, et al.
Cancer Pathogenesis and Therapy (2025)
Open Access
Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
Mi Young Lim, Seungpyo Hong, Young‐Do Nam
Frontiers in Immunology (2025) Vol. 15
Open Access
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access
Tumor immunology and immunotherapy for endometrial cancer
Kosuke Murakami, Shiki Takamura, Kazuhiro Kakimi, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-12
Open Access
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage
J.-M. L’Orphelin, A. Dompmartin, Brigitte Dréno
Pigment Cell & Melanoma Research (2025) Vol. 38, Iss. 2
Open Access
Overview on biomarkers for immune oncology drugs
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Assessing the impact of probiotics on immunotherapy effectiveness and antibiotic-mediated resistance in cancer: a systematic review and meta-analysis
Shuya Zhao, Zhenzhou Lü, Fangmin Zhao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
SITC strategic vision: prevention, premalignant immunity, host and environmental factors
Sasha E. Stanton, Kristin G. Anderson, Tullia C. Bruno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010419-e010419
Open Access
Host-microbe-cancer interactions on-a-chip
Mauricio G. C. Sousa, Danielle S.K. Brasino, Madeline Krieger, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
The therapeutic promise of probiotic Bacteroides fragilis (BF839) in cancer immunotherapy
Kunwei Peng, Yuqing Li, Qijun Yang, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access

Scroll to top